Skip to content

Clinical trials

Terminated Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Terminated Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20101
20121
20143
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Ariad Pharmaceuticals1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
European Society for Blood and Marrow Transplantation1
GWT-TUD GmbH1
Pfizer1
Prof. Dr. Nikolas von Bubnoff1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive9
Leukemia4
Bone Marrow Diseases2
Leukemia, Myeloid2
Leukemia, Myeloid, Chronic-Phase2
Blast Crisis1
Bronchiolitis Obliterans Syndrome1
Hematologic Diseases1
Hematologic Neoplasms1
Immune System Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.